References
- Boeckxstaens GE, Rohof WO. Pathophysiology of gastroesophageal reflux disease. Gastroenterol Clin North Am. 2014;43:15–25.
- Herregods TVK, Bredenoord AJ, Smout A. Pathophysiology of gastroesophageal reflux disease: new understanding in a new era. Neurogastroenterol Motil. 2015;27:1202–1213.
- Rubenstein JH, Chen JW. Epidemiology of gastroesophageal reflux disease. Gastroenterol Clin North Am. 2014;43:1–14.
- Dent J, El-Serag HB, Wallander MA, et al. Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut. 2005;54:710–717.
- Hansen JM, Wildner-Christensen M, Schaffalitzky de Muckadell OB, et al. Gastroesophageal reflux symptoms in a Danish population: a prospective follow-up analysis of symptoms, quality of life, and health-care use. Am J Gastroenterol. 2009;104:2394–2403.
- El-Serag HB. Time trends of gastroesophageal reflux disease: a systematic review. Clin Gastroenterol Hepatol. 2007;5:17–26.
- Friedenberg FK, Hanlon A, Vanar V, et al. Trends in gastroesophageal reflux disease as measured by the National Ambulatory Medical Care Survey. Dig Dis Sci. 2010;55:1911–1917.
- Rasmussen S, Jensen TH, Henriksen SL, et al. Overlap of symptoms of gastroesophageal reflux disease, dyspepsia and irritable bowel syndrome in the general population. Scand J Gastroenterol. 2015;50:162–169.
- Vakil N, van Zanten SV, Kahrilas P, et al. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol. 2006;101:1900–1920. quiz 1943.
- Reimer C, Bytzer P. A population-based survey to assess troublesome symptoms in gastroesophageal reflux disease. Scand J Gastroenterol. 2009;44:394–400.
- Katz PO, Gerson LB, Vela MF. Guidelines for the diagnosis and management of gastroesophageal reflux disease. Am J Gastroenterol. 2013;108:308–328. quiz 329.
- Danish Society for Gastroenterology. Gastroesophageal Reflux Disease: Diagnosis and Treatment. [cited 2019 Jan 16]. Available from: https://dsgh.dk/index.php/ovre-gi/gastrooesofageal-reflukssygdom-diagnostik-behandling.
- Gyawali CP, Fass R. Management of gastroesophageal reflux disease. Gastroenterology. 2018;154:302–318.
- Statistics Denmark. [cited 2019 Jan 16]. Available from: https://www.dst.dk/da/Statistik/emner/befolkning-og-valg/befolkning-og-befolkningsfremskrivning/folketal.
- Lynge E, Sandegaard JL, Rebolj M. The Danish national patient register. Scand J Public Health. 2011;39:30–33.
- Schmidt M, Schmidt SAJ, Sandegaard JL, et al. The Danish National patient registry: a review of content, data quality, and research potential. Clin Epidemiol. 2015;7:449–490.
- Nomesco N-S. Nordic medico-statistical committee. NOMESCO classification of surgical procedures (NCSP), version 1.16. Copenhagen: NOMESCO; 2011.
- Pottegård A, Schmidt SAJ, Wallach-Kildemoes H, et al. Data resource profile: the Danish national prescription registry. Int J Epidemiol. 2017;46:798.
- Schmidt M, Pedersen L, Sørensen HT. The Danish Civil Registration System as a tool in epidemiology. Eur J Epidemiol. 2014;29:541–549.
- Quan H, Li B, Couris CM, et al. Updating and validating the charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol. 2011;173:676–682.
- The Register of Medicinal Product Statistics. [cited 2018 Dec 30]. Available from: http://www.medstat.dk
- Ruszniewski P, Soufflet C, Barthélémy P. Nonsteroidal anti-inflammatory drug use as a risk factor for gastro-oesophageal reflux disease: an observational study. Aliment Pharmacol Ther. 2008;28:1134–1139.
- Haastrup P, Paulsen MS, Zwisler JE, et al. Rapidly increasing prescribing of proton pump inhibitors in primary care despite interventions: a nationwide observational study. Eur J Gen Pr. 2014;20:290–293.
- Lødrup A, Reimer C, Bytzer P. Use of antacids, alginates and proton pump inhibitors: a survey of the general Danish population using an internet panel. Scand J Gastroenterol. 2014;49:1044–1050.
- Pottegård A, Broe A, Hallas J, et al. Use of proton-pump inhibitors among adults: a Danish nationwide drug utilization study. Therap Adv Gastroenterol. 2016;9:671–678.
- Maret-Ouda J, Wahlin K, Artama M, et al. Cohort profile: the Nordic Antireflux Surgery Cohort (NordASCo). BMJ Open. 2017;7:e016505–e016508.
- Thygesen SK, Christiansen CF, Christensen S, et al. The predictive value of ICD-10 diagnostic coding used to assess Charlson comorbidity index conditions in the population-based Danish National Registry of Patients. BMC Med Res Methodol. 2011;11:83.
- Lassen A, Hallas J, Schaffalitzky de Muckadell OB. Complicated and uncomplicated peptic ulcers in a Danish county 1993-2002: a population-based cohort study. Am J Gastroenterology. 2006;101:945–953.
- Sørensen HT, Steffensen FH, Ejlersen E, et al. Research in the Danish health service system: completeness and validity of prescription data, illustrated by analysis of utilization of oral anticoagulants. Int J Risk Saf Med. 1995;7:33–41.
- Sørensen HT, Hansen I, Ejlersen E, et al. Identification of patients treated with strong analgesics: an assessment of two Danish information systems with respect to epidemiological research. J Med Syst. 1996;20:57–65.
- Ruigómez A, Rodríguez LAG, Wallander MA, et al. Endoscopic findings in a cohort of newly diagnosed gastroesophageal reflux disease patients registered in a UK primary care database. Dis Esophagus. 2008;21:251–256.
- Locke G, Talley N, Fett S, et al. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology. 1997;112:1448–1456.
- Ness-Jensen E, Lindam A, Lagergren J, et al. Changes in prevalence, incidence and spontaneous loss of gastro-oesophageal reflux symptoms: a prospective population-based cohort study, the HUNT study. Gut. 2012;61:1390–1397.